
|
Are
you using the best research tools to
understand your market? Are your data reliable and is your
sample representative? |
|
| FactPlusTM
is a
reality-based patient records study. It can help you assess
market growth potential with much more precision than
other methodologies; identify hidden growth opportunities in a
new/ existing market (e.g., off label usage for target drug);
and improve forecasting accuracy with respect to costs,
revenue potential, and profitability. This study is necessary
to understand such factors as dosing and titration (by
diagnosis, duration of treatment), switching behaviors/
patterns, and patient characteristics. |
|
|
|

|
Is
your product an injectable drug that is soon to be launched or
that is currently competing in a highly dynamic market?
Do
you have an accurate and reliable system for tracking changes
in post-launch patient usage/ market share of your drug vs.
each competitor?
|
|
|
Tracker
PlusTM
is a reality-based patient records product providing accurate
metrics related to effects on market share of
§
the
volume of and also
§
the
kinds of patients
receiving your drug and each competitor drug.
Tracker PlusTM
looks at the facts while also
capturing important physician perceptions.
It provides accurate measures of changing physician
“mind share” for your drug and for each key competitor
drug.
Tracker
PlusTM
could be expanded periodically to gain insights into newly
emerged issues such as
§
the
major factors that promote or drive volume changes
§
effects
on market share of bundling/rebates/discounts
by competitors
§
effects
on market share of usage factors such as dosing and
suitability for specific sites or patient conditions
Tracker
PlusTM study rounds can be conducted monthly,
quarterly, or semiannually.
The frequency can be increased or decreased as market
needs permit. |
|
|
|
|

|
Are
there gaps in your primary annual research? Are you aware of a
bias in your data, but unsure how that bias affects results? |
|
| RealityCheckTM
is a product used on an as needed basis. This product
increases your ROI on your primary sources of annual research.
This product determines biases, fills in gaps, and expands
insight into your primary
annual research (Internet
studies, ATU studies, panel, or other nonrepresentative/
convenience sampling). |
| |
|
|
Do
all of your research projects together yield ONE cohesive
story? Does your ATU study disagree in some areas with your
Chart audit/ patient records study?
|
|
| The
Problem: Pharmaceutical companies often purchase separate ATU
and patient records research. Thus, they receive two outputs,
a subjective study and a factual patient records study. Often,
a conflict exists between what physicians perceive they do
versus what they actually do. This is not to say that
physicians intentionally misrepresent their actions. Instead
physician decisions are often unconscious and derived from
experience, knowledge, and habit. It is impossible to
“correct” a perceptual questionnaire without the aid of a
fact-based patient records study. Thus, physician perception
and patient reality are often at odds, disabling both valid
studies.
The Solution:
FactOp™,
the only product of its kind, is designed to give you the
complete picture of your marketplace by obtaining 1) facts
through patient records research, 2) participant opinion
through a “sister” ATU study, and 3) the difference
between “reality” and perception.
Conducting both studies with the same firm using the
same physicians enables better marketing strategies and a
greater understanding of physicians.
Examples
of benefits are:
-
Further
uncover the differences in characteristics of physicians
who are
heavy prescribers of competitor drugs
-
More
easily integrate data from the primary research conducted
by a company with APLD and the myriad other secondary data
purchased by a client company.
-
Enhanced
forecasting
-
Understand
"today" through a factual patient records
study
-
Forecast
the changing dynamics of tomorrow through ATU/
perceptual research
|
| |
 |